So you feel that 2 FDA approved treatments are not worth 100 million in market cap?
Again APPROVED drug and APPROVED device are not worth 100 million... When the company was trying to get these approvals it was worth over a billion. Now that they have approval they are worth 1/10th the previous value?
The product isn't the issue. It's the actual stock itself. There's over 15m shares lower than $3.6, so as soon as this spikes to $4, they naked short it and start all over again. That's why there's over 5 million in volume and we are at $3.76.